Fear, fight, familiarize: the experiences of people living with relapsing-remitting multiple sclerosis and taking oral medication

References

• Brinkmann, S. (2007). Varieties of interviewing: Epistemic and doxastic. Tidsskrift for Kvalitativ Metodeudvikling, 42, 30–14.
   Google Scholar
• Browne, P., Chandraratna, D., Angood, C., Tremlett, H., Baker, C., Taylor, B. V., & Thompson, A. J. (2014). Atlas of multiple sclerosis 2013: A growing global problem with widespread inequity. Neurology, 83, 1022–1024.
   PubMed Web of Science ®Google Scholar
• Carder, P. C., Vuckovic, N., & Green, C. A. (2003). Negotiating medications: Patient perceptions of long-term medication use. Journal of Clinical Pharmacy and Therapeutics, 28(5), 409–417.
   PubMed Web of Science ®Google Scholar
• Carel, H. (2016). Phenomenology of Illness. Oxford: Oxford University Press.
   Google Scholar
• Compston, A., & Coles, A. (2008). Multiple sclerosis. Lancet, 372(9648), 1502–1517.
   PubMed Web of Science ®Google Scholar
• Costello, K., Halper, J., Kalb, R., Skutnik, L., & Rapp, R. (2016, March). The use of disease modifying therapies in multiple sclerosis: Principles and current evidence. Multiple Sclerosis Coalition, p. 2017
   Google Scholar
• Crist, J. D., & Tanner, C. A. (2003). Interpretation/analysis methods in hermeneutic interpretive phenomenology. Nursing Research, 52(3), 202–205.
   PubMed Web of Science ®Google Scholar
• Dahlberg, K., Dahlberg, H., & Nyström, M. (2008). Reflective lifeworld research (2nd ed.). Lund: Studentlitteratur.
   Google Scholar
• Dahlberg, K., Todres, L., & Galvin, K. (2009). Lifeworld-led healthcare is more than patient-led care: An existential view of well-being. Medicine, Health Care, and Philosophy, 12, 265–271.
   PubMed Web of Science ®Google Scholar
• Dargahi, N., Katsara, M., Tselios, T., Androutsou, M. E., De Courten, M., Matsoukas, J., & Apostolopoulos, V. (2017). Multiple sclerosis: Immunopathology and treatment update. Brain Sciences, 7, 78.
   PubMed Web of Science ®Google Scholar
• Dennison, L., McCloy Smith, E., Bradbury, K., & Galea, I. (2016). How do people with multiple sclerosis experience prognostic uncertainty and prognosis communication? A qualitative study. PLoS One, 11(7), e0158982.
   PubMed Web of Science ®Google Scholar
• Di Battista, G., Bertolotto, A., Gasperini, C., Ghezzi, A., Maimone, D., & Solaro, C. (2014). Multiple sclerosis state of the art (SMART): A qualitative and quantitative analysis of therapy’s adherence, hospital reliability’s perception, and services provided quality. Multiple Sclerosis International, 2014, 75231.
   Google Scholar
• Farmacotherapeutisch Kompas. (2017). Retrieved from http://www.farmacotherapeutischkompas.nl/bladeren/indicatieteksten/multipele_sclerose#multipele_sclerose_overzicht_indicatietekst
   Google Scholar
• Finlay, F. (2003). The intertwining of body, self and world: A phenomenological study of living with recently-diagnosed multiple sclerosis. Journal of Phenomenological Psychology, 34(2), 157–178.
   Google Scholar
• Finlay, L. (2009). Debating phenomenological research methods. Phenomenology & Practice, 3(1), 6–25.
   Google Scholar
• Finlay, L. (2011). Phenomenology for therapists: Researching the lived world. Oxford: Wiley-Blackwell.
   Google Scholar
• Freeman, L. (2014). Toward a phenomenology of mood. The Southern Journal of Philosophy, 52(4), 445–476.
   Web of Science ®Google Scholar
• Gadow, S. (1980). Body and Self: A dialectic. The Journal of Medicine and Philosophy, 5(3), 172–185.
   PubMed Web of Science ®Google Scholar
• Geneesmiddeleninformatiebank. (2018). Retrieved from http://www.geneesmiddeleninformatiebank.nl/nl
   Google Scholar
• Halpern, R., Agarwal, S., Borton, L., Oneacre, K., & Lopez-Bresnahan, M. V. (2011). Adherence and persistence among multiple sclerosis patients after one immunomodulatory therapy failure: Retrospective claims analysis. Advances in Therapy, 28(9), 761–775.
   PubMed Web of Science ®Google Scholar
• He, D., Zhang, C., Zhao, X., Zhang, Y., Dai, Q., Li, Y., & Chu, L. (2016). Teriflunomide for multiple sclerosis. Cochrane Database of Systematic Reviews, 22(3), CD009882.
   Google Scholar
• Heidegger, M. (1962). Being and Time ( J. Macquarrie and E. Robinson, trans.). New York, NY: Harper & Row Publishers. Translated from Heidegger, M. (1927). Sein und Zeit. Tübingen: Max Niemeyer Verlag.
   Google Scholar
• Husserl, E. (1989). Ideas pertaining to a pure phenomenology and to a phenomenological philosophy-second book: Studies in the phenomenology of constitution ( R. Rojcewicz and A. Schuwer, trans.). Dordrecht: Kluwer.
   Google Scholar
• Jongen, P. J., Hengstman, G., Hupperts, R., Schrijver, H., Gilhuis, J., Vliegen, J. H., … Borm, G. (2011). Drug adherence and multidisciplinary care in patients with multiple sclerosis: Protocol of a prospective, web-based, patient-centred, nationwide, Dutch cohort study in glatiramer acetate treated patients (CAIR study). BMC Neurology, 11, 40.
   PubMed Web of Science ®Google Scholar
• Klauern, T., & Zettl, U. K. (2008). Compliance, adherence, and the treatment of multiple sclerosis. Journal of Neurology, 255(Suppl 6), 87–92.
   PubMedGoogle Scholar
• La Mantia, L., Tramacere, I., Firwana, B., Pacchetti, I., Palumbo, R., & Filippini, G. (2016). Fingolimod for relapsing-remitting multiple sclerosis. Cochrane Database of Systematic Reviews, 19(4), CD009371.
   Google Scholar
• Linker, R. A., & Haghikia, A. (2016). Dimethyl fumarate in multiple sclerosis: Latest developments, evidence and place in therapy. Therapeutic Advances in Chronic Disease, 7(4), 198–207.
   PubMed Web of Science ®Google Scholar
• Lowden, D., Lee, V., & Ritchie, J. A. (2014). Redefining self: Patients’ decision making about treatment for multiple sclerosis. The Journal of Neuroscience Nursing, 46(4), E14–E24.
   PubMed Web of Science ®Google Scholar
• Miller, A. E., & Rhoades, R. W. (2012). Treatment of relapsing-remitting multiple sclerosis: Current approaches and unmet needs. Neurology, 25(1), S1–S10.
   Google Scholar
• Miller, C. E., & Jezewski, M. A. (2001). A phenomenologic assessment of relapsing MS patients’ experiences during treatment with interferon beta-1a. The Journal of Neuroscience Nursing, 33(5), 240–244.
   PubMedGoogle Scholar
• Miller, C. E., & Jezewski, M. A. (2006). Relapsing MS patients’ experiences with glatiramer acetate treatment: A phenomenological study. The Journal of Neuroscience Nursing, 38(1), 37–41.
   PubMedGoogle Scholar
• Miller, C. E., Karpinski, M., & Jezewski, M. A. (2012). Relapsing-remitting multiple sclerosis patients’ experience with natalizumab: A phenomenological investigation. International Journal of MS Care, 14(1), 39–44.
   PubMedGoogle Scholar
• Polman, C. H., Reingold, S. C., Banwell, B., Clanet, M., Cohen, J. A., Filippi, M., … Wolinsky, J. S. (2010). Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Annals of Neurology, 69(2), 292–302.
   Web of Science ®Google Scholar
• Rich, S., Graham, M., Taket, A., & Shelley, J. (2013). Navigating the terrain of lived experience: The value of lifeworld existential for reflective analysis. International Journal of Qualitative Methods, 12(1), 498–510.
   Google Scholar
• Salamonsen, A. (2015). Mind the gap! Lay and medical perceptions of risks associated with the use of alternative treatment and conventional medicine. Forschende Komplementarmedizin, 22(1), 24–29.
   Google Scholar
• Sartre, J. P. (1943). L’Étre et le Néant. Paris: Tel Gallimard.
   Google Scholar
• Smith, D. F. (2016). Phenomenology. In E. N. Zalta (Ed.), The stanford encyclopedia of philosophy (Winter2016 ed.). Retrieved from http://plato.stanford.edu/archives/win2016/entries/phenomenology/
   Google Scholar
• Smith, J. A., Flowers, P., & Larkin, M. (2009). Interpretative phenomenological analysis. London, UK: Sage Publications.
   Google Scholar
• Soundy, A., Roskell, C., Elder, T., Collett, J., & Dawes, H. (2016). The psychological processes of adaptation and hope in patients with multiple sclerosis: A thematic analysis. Open Journal of Therapy and Rehabilitation, 4, 22–47.
   Google Scholar
• Tan, H., Cai, Q., Agarwal, S., Stephenson, J. J., & Kamat, S. (2011). Impact of adherence to disease-modifying therapies on clinical and economic outcomes among patients with multiple sclerosis. Advances in Therapy, 28(1), 51–61.
   PubMed Web of Science ®Google Scholar
• Thannhauser, J. E., Mah, J. K., & Metz, L. M. (2009). Adherence of adolescents to multiple sclerosis disease-modifying therapy. Pediatric Neurology, 41(2), 119–123.
   PubMed Web of Science ®Google Scholar
• Todres, L., Galvin, K., & Dahlberg, K. (2006). Lifeworld-led care: Revising a humanizing philosophy that integrates emerging trends. Medicine, Health Care, and Philosophy, 10(1), 53–63.
   PubMedGoogle Scholar
• Toombs, K. (1995). Sufficient unto the day: A life with multiple sclerosis. In S. K. Toombs, D. Barnard, & R. Carson (Eds.), Chronic illness: From experience to policy  (pp. 3–23). Bloomington and Indianapolis: Indiana University Press.
   Google Scholar
• Vagle, M. D. (2014). Crafting phenomenological research. Walnut Creek: Left Coast Press.
   Google Scholar
• Van Capelle, A. D. C., Van der Meide, H., Vosman, F. J., & Visser, L. H. (2017). A qualitative study assessing patient perspectives in the process of decision-making on disease modifying therapies (DMT’s) in multiple sclerosis (MS). PLoS One, 12(8), e0182806.
   PubMed Web of Science ®Google Scholar
• Van Manen, M. (2014). Phenomenology of practice. Meaning-giving methods in phenomenological research and writing. Walnut Creek: Left Coast Press.
   Google Scholar
• Visse, M. A. (2012). Openings for humanization in modern health care practices (PhD thesis), VU A’dam. The Netherlands: VU University Amsterdam.
   Google Scholar
• Vosman, F., & Niemeijer, A. (2017). Rethinking critical reflection on care: Late modern uncertainty and the implications for care ethics. Medicine, Health Care, and Philosophy, 20(4), 465–476.
   PubMed Web of Science ®Google Scholar
• WHO. (2003). Adherence to long-term therapies: Evidence for action. ISBN 9241545992. Switzerland: WHO.
   Google Scholar
• World Medical Association. (2013). Declaration of Helsinki. Ethical principles for medical research involving human subjects. Journal of American Medical Assocation, 310(20), 2191–2194.
   PubMed Web of Science ®Google Scholar
• Yardley, L. (2007). Demonstrating validity in qualitative psychology. In J. A. Smith (Ed.), Qualitative psychology: A practical guide to research methods (pp. 235–251). London: SAGE Ltd.
   Google Scholar